Viewing Study NCT04227769


Ignite Creation Date: 2025-12-24 @ 10:54 PM
Ignite Modification Date: 2026-01-01 @ 4:41 AM
Study NCT ID: NCT04227769
Status: TERMINATED
Last Update Posted: 2025-01-29
First Post: 2020-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IL-1-receptor Antagonist During Cephalic Phase of Insulin Secretion in Health and Type 2 Diabetes
Sponsor: University Hospital, Basel, Switzerland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module